![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![AbbVie](https://www.pharmacompass.com/image/flap/abbvie-corp-adgif-27965.gif)
![AbbVie](https://www.pharmacompass.com/image/flap/abbvie-corp-ad-w33-mob-headergif-39012.gif)
20
Aalidhra Pharmachem Private Limited Nandesari In, based in India, is a pharmaceutical company.
They are recognized for Aalidhra has a niche range of high-quality APIs & Advanced Drug Intermediates for the global generic & branded drug segments.
One of their significant offerings is Lacosamide, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2023-039 - Rev 00
This Chemical Type CEP, issued on July 08, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2992 associated with this CEP further emphasizes